In primary transplantation, we observed no difference in the frequency of donor-derived GFP+ cells in mice repopulated with wild type or Necdin null HSPCs expressing AML-ETO9a at 8 weeks following transplantation (Figure 5A). Here, NDN is linked to acute myeloid leukemia.